E-LIB Suche - Ergebnisse für: Mallinckrodt, C

1

Phase 2 Study Design and New Data from the Phase 1 SAD/MAD ..:

Detke, Michael ; Sabbagh, Marwan ; Holsinger, Leslie J...
Alzheimer's & Dementia. 19 (2023) S24 - p. , 2023

Link: https://doi.org/10.1002/..

2

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C ; Tian, Y ; Aisen, PS...
https://discovery.ucl.ac.uk/id/eprint/10163690/1/jpad.2023.6.pdf. , 2023

Link: https://discovery.ucl.ac..

3

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S ; Aisen, PS ; Barkhof, F...
https://discovery.ucl.ac.uk/id/eprint/10146033/1/BuddHaeberlein2022_Article_TwoRandomizedPhase3StudiesOfAd.pdf. , 2022

Link: https://discovery.ucl.ac..

4

Aligning Estimators With Estimands in Clinical Trials: Putt..:

Mallinckrodt, C. H. ; Bell, J. ; Liu, G....
Therapeutic Innovation & Regulatory Science. 54 (2020) 2 - p. 353-364 , 2020

Link: https://doi.org/10.1007/..

5

Aligning Estimators With Estimands in Clinical Trials: Putt..:

Mallinckrodt, C. H. ; Bell, J. ; Liu, G....
Therapeutic Innovation & Regulatory Science. , 2019

Link: https://doi.org/10.1177/..

6

Efficacy and safety of continuous every-2-week dosing of ix..:

Langley, R.G. ; Papp, K. ; Gooderham, M....
British Journal of Dermatology. 178 (2018) 6 - p. 1315-1323 , 2018

Link: https://doi.org/10.1111/..

7

Recent Developments in the Prevention and Treatment of Miss..:

Mallinckrodt, C. ; Roger, J. ; Chuang-Stein, C....
Therapeutic Innovation & Regulatory Science. 48 (2014) 1 - p. 68-80 , 2014

Link: https://doi.org/10.1177/..

8

A structured framework for assessing sensitivity to missing..:

Mallinckrodt, C.H. ; Lin, Q. ; Molenberghs, M.
Pharmaceutical Statistics. 12 (2012) 1 - p. 1-6 , 2012

Link: https://doi.org/10.1002/..

9

A structured approach to choosing estimands and estimators ..:

Mallinckrodt, C. H. ; Lin, Q. ; Lipkovich, I..
Pharmaceutical Statistics. 11 (2012) 6 - p. 456-461 , 2012

Link: https://doi.org/10.1002/..

10

The impact of analytic method on interpretation of outcomes..:

Prakash, A. ; Risser, R. C. ; Mallinckrodt, C. H.
International Journal of Clinical Practice. 62 (2008) 8 - p. 1147-1158 , 2008

Link: https://doi.org/10.1111/..

11

The impact of analytic method on interpretation of outcomes..:

Prakash, A ; Risser, R C ; Mallinckrodt, C H
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658028. , 2008

Link: http://www.ncbi.nlm.nih...

12

P.2.c.027 The relevance of treating painful somatic symptom..:

Wise, T.N. ; Meyers, A.L. ; Desaiah, D....
European Neuropsychopharmacology. 17 (2007) - p. S356 , 2007

Link: https://doi.org/10.1016/..

13

Patterns of depressive symptom response in duloxetine-treat..:

Shelton, R. C. ; Prakash, A. ; Mallinckrodt, C. H....
International Journal of Clinical Practice. 61 (2007) 8 - p. 1337-1348 , 2007

Link: https://doi.org/10.1111/..

14

(741):

Fishbain, D. ; Hall, J. ; Meyers, A....
The Journal of Pain. 8 (2007) 4 - p. S36 , 2007

Link: https://doi.org/10.1016/..

15

Using Daily Interactive Voice Response Assessments: To Meas..:

Moore, Heidi K ; Wohlreich, Madelaine M ; Wilson, Michael G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922356. , 2007

Link: http://www.ncbi.nlm.nih...